Guardant Health, Inc. (GH)
NASDAQ
Healthcare
Medical - Diagnostics & Research
$152.35
▲ +5.75%
Market Cap
$20.20B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.59
52-Wk Range
40.35-174.08
CEO
Helmy Eltoukhy
Country
US
Currency
USD
Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and CDx versions) and GuardantOMNI. Complementing these diagnostic tools, Guardant Health also provides GuardantINFORM, an in-silico research platform leveraging an extensive clinical-ge…
Open full interactive analysis & DCF →